13F-HR filed by Tetragon Partners GP Ltd
Tetragon Partners GP Ltd filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 28 holding rows worth $474,273,704.
- Accession
- 0000902664-26-001035
- Filer
- CIK 1515070
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 31 entries on the cover page, a total value of $474,273,704 stated on the cover page (in dollars after the unit check, H1), rows summing to $474,273,704 with VALUE read as dollars as filed, 13F file number 028-15287. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTetragon Partners L.P.028-15282
- included managerTetragon Partners UK LLP028-15285
- included managerTetragon Partners US LP028-15284
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UIPATH INC | 90364P105 | CL A | 17,450,000 | $286,005,500 | dollars as filed | |
| KOLIBRI GLOBAL ENERGY INC | 50043K406 | COMMON STOCK | 6,934,504 | $27,252,601 | dollars as filed | |
| LYFT INC | 55087P104 | CL A COM | 1,000,000 | $19,370,000 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 9,500,000 | $18,905,000 | dollars as filed | |
| SPRINKLR INC | 85208T107 | CL A | 2,200,000 | $17,116,000 | dollars as filed | |
| WORKIVA INC COM CL A | 98139A105 | Stock | 150,000 | $12,937,500 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 2,032,455 | $10,202,924 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 22,952 | $6,764,872 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 243,800 | $6,621,608 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 96,935 | $6,435,515 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 194,612 | $5,400,483 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 26,934 | $4,919,226 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 247,997 | $4,850,821 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 143,327 | $4,520,534 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 131,770 | $4,463,050 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 162,018 | $4,410,130 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 166,187 | $4,224,474 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 141,172 | $3,949,993 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 260,771 | $3,713,379 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 272,828 | $3,295,762 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 82,824 | $3,099,274 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 69,287 | $2,929,454 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 11,814 | $2,912,624 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 164,525 | $2,889,882 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 365,369 | $2,221,444 | dollars as filed | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 10,000 | $2,193,600 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 192,518 | $1,724,961 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 43,763 | $943,093 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000902664-26-001035 | this filing | 2026-02-17 | acceptance time not in the bulk data set |